Moreover, high TOP2A mRNA expression was also significantly associated with poor overall survival and diseases free survival of patients with adrenocortical carcinoma, breast invasive carcinoma, kidney renal clear cell carcinoma, kidney renal papillary cell carcinoma, brain lower grade glioma, liver hepatocellular carcinoma, lung adenocarcinoma, mesothelioma, or pancreatic adenocarcinoma. This evidence concerns the gene TOP2A and adrenal cortex carcinoma.